News

Filter

Current filters:

None

7890 to 7899 of 97840 results

Novartis sales in third-quarter 2012 disappoint; EPS in line

25-10-2012

Swiss drug major Novartis (NOVN: VX) reported third-quarter 2012, showing that net sales reached $13.8…

FinancialNovartisPharmaceutical

Eli Lilly 3rd-qtr 2012 sales fall on Zyprexa generic competition

25-10-2012

US pharma major Eli Lilly (NYSE: LLY) yesterday reported third-quarter 2012 financial results, showing…

Eli LillyFinancialPharmaceutical

AstraZeneca 3rd-qtr 2012 takes heavy hit from generics

25-10-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) revealed this morning that group sales for the third…

AstraZenecaFinancialPharmaceutical

Bristol-Myers goes into red, on charges and Plavix sales slump

25-10-2012

US drug major Bristol-Myers Squibb (NYSE: BMY) reported financial results for the third quarter of 2012,…

Bristol-Myers SquibbFinancialPharmaceutical

UK govt sets out proposals to cut risks for pharmaceutical research

24-10-2012

A new consultation launched yesterday by the Department for Business, Innovation & Skills (BIS) sets…

BiotechnologyEuropePatentsPharmaceuticalRegulationResearch

European Parliament approves deal with Israel to ease trade in medicines

24-10-2012

European Union-certified pharmaceuticals will be exported to Israel and vice-versa without requiring…

EuropeLegalMarkets & MarketingPharmaceuticalRest of the World

Shire links with Italian foundation for research on rare diseases

24-10-2012

Shire (LSE: SHP) has announced a long-term, broad based, multi-indication research collaboration in rare…

PharmaceuticalRare diseasesResearchShire

7890 to 7899 of 97840 results

COMPANY SPOTLIGHT

Menarini

Back to top